{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:49:10Z","timestamp":1759366150288,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.arteri.2019.10.007","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T08:34:35Z","timestamp":1579595675000},"page":"126-128","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["S\u00edndrome coronario agudo como primera manifestaci\u00f3n de trombocitemia esencial: un reto para los cardi\u00f3logos"],"prefix":"10.1016","volume":"32","author":[{"given":"Francisco Javier","family":"Garcip\u00e9rez de Vargas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Antonia","family":"Ram\u00edrez Ariza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"S\u00e1nchez Calder\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro","family":"Mellado Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Garc\u00eda Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Javier","family":"G\u00f3mez Barrado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arteri.2019.10.007_bib0050","first-page":"133","volume":"94","author":"Tefferi","year":"2019","journal-title":"Am J Hematol. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification, and management."},{"key":"10.1016\/j.arteri.2019.10.007_bib0055","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2141.1996.d01-1729.x","article-title":"The reduction of large von Willebrand factor mult\u00edmers in plasma in essential thrombocythemia is related to the platelet count","volume":"93","author":"Van Genderen","year":"1996","journal-title":"Br J Haematol."},{"key":"10.1016\/j.arteri.2019.10.007_bib0060","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.1182\/blood-2011-02-339002","article-title":"Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: An international study of 891 patients","volume":"117","author":"Carobbio","year":"2011","journal-title":"Blood."},{"key":"10.1016\/j.arteri.2019.10.007_bib0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.23632","article-title":"Evaluation of the prevalence and prospective clinical impact of the JAK2 V617F mutation in coronary patients","volume":"89","author":"Muendlein","year":"2014","journal-title":"Am J Hematol."},{"key":"10.1016\/j.arteri.2019.10.007_bib0070","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00380-016-0798-x","article-title":"JAK2 mutation and acute coronary syndrome complicated with stent thrombosis","volume":"31","author":"Inami","year":"2016","journal-title":"Heart Vessels."},{"key":"10.1016\/j.arteri.2019.10.007_bib0075","first-page":"707438","article-title":"Reactive Thrombocytosis Associated with Acute Myocardial Infarction following STEMI with Percutaneous Coronary Intervention","volume":"2013","author":"Dumrongmongcolgul","year":"2013","journal-title":"Case Rep Cardiol."},{"key":"10.1016\/j.arteri.2019.10.007_bib0080","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.recesp.2017.11.014","article-title":"Actualizaci\u00f3n ESC 2017 sobre el tratamiento antiagregante plaquetario doble en la enfermedad coronaria, desarrollada en colaboraci\u00f3n con la EACTS","volume":"71","author":"Valgimigli","year":"2018","journal-title":"Rev Esp Cardiol."},{"key":"10.1016\/j.arteri.2019.10.007_bib0085","first-page":"178","article-title":"Evaluation of platelet reactivity using P2Y12 reaction units in acute coronary syndrome with essential thrombocythemia: A case report","volume":"11","author":"Yoshida","year":"2015","journal-title":"J Cardiol Cases."},{"key":"10.1016\/j.arteri.2019.10.007_bib0090","first-page":"985253","article-title":"Heparin-Induced Thrombocytopenia in a Patient with Essential Thrombocythemia: A Case Based Update","volume":"2015","author":"Noel","year":"2015","journal-title":"Case Rep Hematol."}],"container-title":["Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916819301457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0214916819301457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:32:01Z","timestamp":1759325521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0214916819301457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0214916819301457"],"URL":"https:\/\/doi.org\/10.1016\/j.arteri.2019.10.007","relation":{},"ISSN":["0214-9168"],"issn-type":[{"type":"print","value":"0214-9168"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"S\u00edndrome coronario agudo como primera manifestaci\u00f3n de trombocitemia esencial: un reto para los cardi\u00f3logos","name":"articletitle","label":"Article Title"},{"value":"Cl\u00ednica e Investigaci\u00f3n en Arteriosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arteri.2019.10.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Sociedad Espa\u00f1ola de Arteriosclerosis. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}